Great Lakes Advisors LLC Invests $2.40 Million in Integer Holdings Corporation $ITGR

Great Lakes Advisors LLC purchased a new stake in shares of Integer Holdings Corporation (NYSE:ITGR) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 25,641 shares of the medical equipment provider’s stock, valued at approximately $2,396,000.

A number of other institutional investors have also recently added to or reduced their stakes in ITGR. Irenic Capital Management LP bought a new stake in shares of Integer in the fourth quarter worth $99,109,000. Alliancebernstein L.P. lifted its position in shares of Integer by 885.1% during the second quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock worth $136,016,000 after purchasing an additional 993,810 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Integer by 1,141.6% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 819,046 shares of the medical equipment provider’s stock worth $72,076,000 after purchasing an additional 753,081 shares during the last quarter. Millennium Management LLC grew its stake in Integer by 3,350.2% in the fourth quarter. Millennium Management LLC now owns 677,108 shares of the medical equipment provider’s stock worth $53,106,000 after purchasing an additional 657,483 shares in the last quarter. Finally, J. Goldman & Co LP bought a new stake in Integer in the fourth quarter valued at about $40,531,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Wells Fargo & Company lifted their price objective on shares of Integer from $84.00 to $127.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 4th. Freedom Capital lowered shares of Integer from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 4th. Truist Financial downgraded shares of Integer from a “buy” rating to a “hold” rating and raised their price target for the stock from $110.00 to $127.00 in a research report on Monday, August 3rd. Finally, KeyCorp lowered shares of Integer from an “overweight” rating to a “sector weight” rating in a report on Monday, August 3rd. One research analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $109.86.

Integer Stock Performance

Shares of ITGR opened at $125.22 on Friday. The firm has a fifty day moving average of $104.12 and a 200-day moving average of $93.10. The company has a market cap of $4.26 billion, a price-to-earnings ratio of 34.21, a price-to-earnings-growth ratio of 2.97 and a beta of 0.61. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.41 and a current ratio of 3.73. Integer Holdings Corporation has a 1 year low of $62.00 and a 1 year high of $126.14.

Integer (NYSE:ITGR) last released its quarterly earnings data on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.38 by $0.22. The business had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter last year, the company earned $1.55 EPS. As a group, equities analysts anticipate that Integer Holdings Corporation will post 6.08 earnings per share for the current year.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.